The FDA has approved ciclesonide inhalation aerosol (Alvesco) and a new indication for natalizumab intravenous infusion (Tysabri). Medscape Medical News
Recent controversies about heparin contamination from China and ESA adverse effects raise questions about drug safety and FDA oversight. Medscape Nephrology
Multiple factors, including severity of illness, predict apnea following immunization in hospitalized infants, researchers report in the March issue of Pediatrics. Reuters Health Information
Efficient translation of basic vaccine research to clinical therapies will depend upon the availability of appropriate animal models. Future Microbiology
These 3 patient cases will help the healthcare team to recognize the early stages of RA, assess disparities in care among minorities, and consider a variety of comorbidities during RA management. Medscape Family Medicine
